A role for DNA mismatch repair in sensing and responding to fluoropyrimidine damage

Oncogene

Volumn 22, Issue 47, 2003, Pages 7376-7388

  Meyers, Mark ^a   Hwang, Arlene ^a   Wagner, Mark W ^a   Bruening, Andrew J ^a   Veigl, Martina L ^b   Sedwick, W David ^c   Boothman, David A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

5 fluoro 20 deoxycytidine; 5 fluoro 20 deoxyuridine; 5 fluorouracil; Colon cancer treatment; DNA damage tolerance; Futile cycles of repair

Indexed keywords

5-FLUOROPYRIMIDINE; CYTIDINE; DRUG DERIVATIVE; FLUOROPYRIMIDINE; PYRIMIDINE DERIVATIVE;

ANIMAL; BASE MISPAIRING; DNA DAMAGE; DNA REPAIR; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; NEOPLASM; REVIEW; RNA PROCESSING;

ANIMALS; BASE PAIR MISMATCH; CYTIDINE; DNA DAMAGE; DNA REPAIR; HUMANS; NEOPLASMS; PYRIMIDINES; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 0642374238     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1206941     Document Type: Article

References (147)

1. Abraham RT. (2001). Genes Dev., 15, 2177-2196.
2. Adamson AW, Kim W-J, Shangary S, Baskaran R and Brown KD. (2002). J. Biol. Chem. 277, 38222-38229.
3. Aebersold PM. (1979). Cancer Res., 39, 808-810.
4. Agami R, Blandino G, Oren M and Shaul Y. (1999). Nature (Lond.), 399, 809-813.
5. Au KG, WelshK and ModrichP. (1992). J. Biol. Chem., 267, 12142-12148.
6. Baskaran R, Wood LD, Whitaker LL, Canman CE, Morgan SE, Xu Y, Barlow C, Baltimore D, Wynshaw-Boris A, Kastan MB and Wang JYJ. (1997). Nature (Lond.), 387, 516-519.
7. Bebenek K, Roberts JD and Kunkel TA. (1992). J. Biol. Chem., 267, 3589-3596.
8. Bellacosa A. (2001). Cell Death Differ., 8, 1076-1092.
9. Bellacosa A, Cicchillitti L, Schepis F, Riccio A, Yeung AT, Matsumoto Y, Golemis EA, Genuardi M and Neri G. (1999). Proc. Natl. Acad. Sci. USA, 96, 3969-3974.
10. Bernstein C, Bernstein H, Payne CM and Garewal H. (2002). Mutat. Res., 511, 145-178.
11. Berry SE, Davis TW, Schupp JE, Hwang HS, de Wind N and Kinsella TJ. (2000). Cancer Res., 60, 5773-5780.
12. Berry SE, Garces C, Hwang HS, Kunugi K, Meyers M, Davis TW, Boothman DA and Kinsella TJ. (1999). Cancer Res., 59, 1840-1845.
13. Bianchi V, Pontis E and Reichard P. (1987). Mol. Cell. Biol., 7, 4218-4224.
14. Boothman DA, Briggle TV and Greer S. (1985). Mol. Pharmacol., 27, 584-594.
15. Boothman DA, Briggle TV and Greer S. (1987a). Cancer Res., 47, 2344-2353.
16. Boothman DA, Briggle TV and Greer S. (1987b). Cancer Res., 47, 2354-2362.
17. Boothman DA, Schlegel R and Pardee AB. (1988). Mutat. Res., 202, 393-411.
18. Buermeyer AB, Wilson-Van Patten C, Baker SM and Liskay RM. (1999). Cancer Res., 59, 538-541.
19. Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L, Williams J, Lengauer C, Kinzler KW and Vogelstein B. (1999). J. Clin. Invest., 104, 263-269.
20. Caradonna SJ and Adamkiewicz DM. (1984). J. Biol. Chem., 259, 5459-5464.
21. Caradonna SJ and Cheng YC. (1980). Mol. Pharmacol., 18, 513-520.
22. Carethers JM, Hawn MT, Chauhan DP, Luce MC, Marra G, Koi M and Boland CR. (1996). J. Clin. Invest., 98, 199-206.
23. Coll M, Saal D, Frederick CA, Aymami J, RichA and Wang AH-J. (1989). Nucleic Acids Res., 17, 911-923.
24. Costanzo A, Merlo P, Pediconi N, Fulco M, Sartorelli V, Cole PA, Fontemaggi G, Fanciulli M, Schiltz L, Blandino G, Balsano C and Levrero M. (2002). Mol. Cell, 9, 175-186.
25. Davis TW, Wilson-Van Patten C, Meyers M, Kunugi KA, Cuthill S, Reznikoff C, Garces C, Boland CR, Kinsella TJ, Fishel R and Boothman DA. (1998). Cancer Res., 58, 767-778.
26. Dianov GL, Timchenko TV, Sinitsina OI, Kuzminov AV, Medvedev OA and Salganik RI. (1991). Mol. Gen. Genet., 225, 448-452.
27. Domin BA, Mahony WB and Zimmerman TP. (1993). Biochem. Pharmacol., 46, 503-510.
28. Doong S-L and Dolnick BJ. (1988). J. Biol. Chem., 263, 4467-4473.
29. Duckett DR, Bronstein SM, Taya Y and ModrichP. (1999). Proc. Natl. Acad. Sci. USA, 96, 12384-12388.
30. Duker NJ, Jensen DE, Hart DM and Fishbein DE. (1982). Proc. Natl. Acad. Sci. USA, 79, 4878-4882.
31. Durocher D and Jackson SP. (2001). Curr. Opin. Cell Biol., 13, 225-231.
32. el-Hajj HH, Wang L and Weiss B. (1992). J. Bacteriol., 174, 4450-4456.
33. Fazakerley GV, Sowers LC, Eritja R, Kaplan BE and Goodman MF. (1987). J. Biomol. Struct. Dyn., 5, 639-650.
34. Fernandes DJ and Cranford SK. (1986). Cancer Res., 46, 1741-1747.
35. Fink D, Aebi S and Howell SB. (1998). Clin. Cancer Res., 4, 1-6.
36. Fishel R. (1998). Genes Dev., 12, 2096-2101.
37. Fishel R. (1999). Nat. Med., 5, 1239-1241.
38. Fisher EF and Caruthers MH. (1979). Nucleic Acids Res., 7, 401-416.
39. Fleisher AS, Esteller M, Tamura G, Rashid A, Stine OC, Yin J, Zou TT, Abraham JM, Kong D, Nishizuka S, James SP, Wilson KT, Herman JG and Meltzer SJ. (2001). Oncogene, 20, 329-335.
40. Foray N, Marot D, Randrianarison V, Venezia ND, Picard D, Perricaudet M, Favaudon V and Jeggo P. (2002). Mol. Cell. Biol., 22, 4020-4032.
41. Freese E. (1959). J. Mol. Biol., 1, 87-105.
42. Friedkin M. (1973). Adv. Enzymol., 38, 235-292.
43. Gill JE, Mazrimas JA and Bishop Jr CC. (1974). Biochim. Biophys. Acta, 335, 330-348.
44. Glazer RI and Hartman KD. (1981). Mol. Pharmacol., 19, 117-121.
45. Glazer RI and Lloyd L. (1982). Mol. Pharmacol., 21, 468-473.
46. Glickman BW. (1982). Molecular and Cellular Mechanisms of Mutagenesis Generoso WM (ed). Plenum Press: New York, NY, pp. 65-87.
47. Goel A, Arnold CN, Niedzwiecki D, Chang DK, Ricciardiello L, Carethers JM, Dowell JM, Wasserman L, Compton C, Mayer RJ, Bertagnolli MM and Boland CR. (2003). Cancer Res., 63, 1608-1614.
48. Gong JG, Costanzo A, Yang H-Q, Melino G, Kaelin Jr WG, Levrero M and Wang JYJ. (1999). Nature (Lond.), 399, 806-809.
49. Goulian M, Bleile B and Tseng BY. (1980a). J. Biol. Chem., 255, 10630-10637.
50. Goulian M, Bleile B and Tseng BY. (1980b). Proc. Natl. Acad. Sci. USA, 77, 1956-1960.
51. Gradia S, Subramanian D, Wilson T, Acharya S, Makhov A, GriffithJ and Fishel R. (1999). Mol. Cell, 3, 255-261.
52. Grem JL. (1996). Cancer Chemotherapy and Biotherapy: Principles and Practice Longo DL (ed). Lippincott: Philadelphia, PA, pp. 149-211.
53. Grem JL. (1997). Semin. Radiat. Oncol., 7, 249-259.
54. Grem JL, Mulcahy RT, Miller EM, Allegra CJ and Fischer PH. (1989). Biochem. Pharmacol., 38, 51-59.
55. Habener JF, Vo CD, Le DB, Gryan GP, Ercolani L and Wang AH-J. (1988). Proc. Natl. Acad. Sci. USA, 85, 1735-1739.
56. Hardeland U, Bentele M, Lettieri T, Steinacher R, Jiricny J and Schar P. (2001). Prog. Nucleic Acid Res. Mol. Biol., 68, 235-253.
57. Hartwell LH and Kastan MB. (1994). Science (Wash. DC), 266, 1821-1828.
58. Haushalter KA, Stukenberg PT, Kirschner MW and Verdine GL. (1999). Curr. Biol., 174-185.
59. Hawn MT, Umar A, Carethers JM, Marra G, Kunkel TA, Boland CR and Koi M. (1995). Cancer Res., 55, 3721-3725.
60. Heidelberger C, Chaudhuri NK, Danneberg P, Mooren D, Griesbach L, Duschinsky R, Schnitzer RJ, Pleven E and Scheiner J. (1957). Nature (Lond.), 179, 663-666.
61. Heidelberger C, GriesbachL, Cruz D, Schnitzer RJ and Grunberg E. (1958). Proc. Soc. Exp. Biol. Med., 97, 470-475.
62. HendrichB, Hardeland U, Ng H-H, Jiricny J and Bird A. (1999). Nature (Lond.), 401, 301-304.
63. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA and Baylin SB. (1998). Proc. Natl. Acad. Sci. USA, 95, 6870-6875.
64. Hickman MJ and Samson LD. (1999). Proc. Natl. Acad. Sci. USA, 96, 10764-10769.
65. HsiehP. (2001). Mutat. Res., 486, 71-87.
66. Ingraham HA and Goulian M. (1982). Biochem. Biophys. Res. Commun., 109, 746-752.
67. Ingraham HA, Tseng BY and Goulian M. (1980). Cancer Res., 40, 998-1001.
68. Ingraham HA, Tseng BY and Goulian M. (1982). Mol. Pharmacol., 21, 211-216.
69. Jacob S, Aguado M, Fallik D and Praz F. (2001). Cancer Res., 61, 6555-6562.
70. Jiricny J and Nystrom-Lahti M. (2000). Curr. Opin. Genet. Dev., 10, 157-161.
71. Johnston PG, Takimoto CH, Grem JL, Chabner BA, Allegra CJ and Chu E. (1996). Cancer Chemother. Biol. Response Modif., 16, 1-27.
72. Jones PA, Benedict WF, Baker MS, Mondal S, Rapp U and Heidelberger C. (1976). Cancer Res., 36, 101-107.
73. Kanamaru R, Kakuta H, Sato T, Ishioka C and Wakui A. (1986). Cancer Chemother. Pharmacol., 17, 43-46.
74. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM and Kolodner R. (1997). Cancer Res., 57, 808-811.
75. Karran P. (2001). Carcinogenesis, 22, 1931-1937.
76. Karran P and Bignami M. (1994). BioEssays, 16, 833-839.
77. Karran P and Hampson R. (1996). Cancer Surv., 28, 69-85.
78. Karran P and Marinus MG. (1982). Nature (Lond.), 296, 868-869.
79. Kashlan OB, Scott CP, Lear JD and Cooperman BS. (2002). Biochemistry, 41, 462-474.
80. Kavli B, Sundheim O, Akbari M, Otterlei M, Nilsen H, Skorpen F, Aas PA, Hagen L, Krokan HE and Slupphaug G. (2002). J. Biol. Chem., 277, 39926-39936.
81. Kaysen J, Spriggs D and Kufe D. (1986). Cancer Res., 46, 4534-4538.
82. Koi M, Umar A, Chauhan DP, Cherian SP, Carethers JM, Kunkel TA and Boland CR. (1994). Cancer Res., 54, 4308-4312.
83. Kolodner RD and Marsischky GT. (1999). Curr. Opin. Genet. Dev., 9, 89-96.
84. Kremer AB, Mikita T and Beardsley GP. (1987). Biochemistry, 26, 391-397.
85. Krokan HE, Nilsen H, Skorpen F, Otterlei M and Slupphaug G. (2000). FEBS Lett., 476, 73-77.
86. Krokan HE, Otterlei M, Nilsen H, Kavli B, Skorpen F, Andersen S, Skjelbred C, Akbari M, Aas PA and Slupphaug G. (2001). Prog. Nucleic Acid Res. Mol. Biol., 68, 365-386.
87. Kufe DW and Major PP. (1981). J. Biol. Chem., 256, 9802-9805.
88. Kufe DW, Major PP, Egan EM and LohE. (1981). J. Biol. Chem., 256, 8885-8888.
89. Kunz BA. (1996). Mutat. Res., 355, 129-140.
90. Kunz BA, Kohalmi SE, Kunkel TA, Mathews CK, McIntosh EM and Reidy JA. (1994). Mutat. Res., 318, 1-64.
91. Lage H and Dietel M. (1999). J. Cancer Res. Clin. Oncol., 125, 156-165.
92. LeClerc JE, Li BG, Payne WL and Cebula TA. (1996). Science (Wash. DC), 274, 1208-1211.
93. Lin X, Ramamurthi K, Mishima M, Kondo A and Howell SB. (2000). Mol. Pharmacol., 58, 1222-1229.
94. Lindahl T. (1993). Nature (Lond.), 362, 709-715.
95. Liu P, Burdzy A and Sowers LC. (2002). Chem. Res. Toxicol., 15, 1001-1009.
96. Lönn U and Lönn S. (1984). Cancer Res., 44, 3414-3418.
97. Lönn U, Lönn S, Nylen U and Winblad G. (1989). Cancer Res., 49, 1085-1089.
98. Major PP, Egan E, Herrick D and Kufe DW. (1982). Cancer Res., 42, 3005-3009.
99. Mao EF, Lane L, Lee J and Miller JH. (1997). J. Bacteriol., 179, 417-422.
100. Mauro DJ, de Riel JK, Tallarida RJ and Sirover MA. (1993). Mol. Pharmacol., 43, 854-857.
101. Maybaum J, Cohen MB and Sadee W. (1981). J. Biol. Chem., 256, 2126-2130.
102. McIntoshEM and Haynes RH. (1997). Acta Biochim. Pol., 44, 159-171.
103. Mekras JA, Boothman DA and Greer SB. (1985). Cancer Res., 45, 5270-5280.
104. Mekras JA, Boothman DA, Perez LM and Greer S. (1984). Cancer Res., 44, 2551-2560.
105. Meyers M, Wagner MW, Hwang H-S, Kinsella TJ and Boothman DA. (2001). Cancer Res., 61, 5193-5201.
106. ModrichP. (1997). J. Biol. Chem., 272, 24727-24730.
107. ModrichP and Lahue R. (1996). Annu. Rev. Biochem., 65, 101-133.
108. Muller A and Fishel R. (2002). Cancer Invest., 20, 102-109.
109. Nehme A, Baskaran R, Aebi S, Fink D, Nebel S, Cenni B, Wang JYJ, Howell SB and Christen RD. (1997). Cancer Res., 57, 3253-3257.
110. Nehme A, Baskaran R, Nebel S, Fink D, Howell SB, Wang JYJ and Christen RD. (1999). Br. J. Cancer, 79, 1104-1110.
111. Newman EM and Santi DV. (1982). Proc. Natl. Acad. Sci. USA, 79, 6419-6423.
112. Nilsson S, Reichard P and Skoog L. (1980). J. Biol. Chem., 255, 9552-9555.
113. Norbury CJ and Hickson ID. (2001). Annu. Rev. Pharmacol. Toxicol., 41, 367-401.
114. Osterman DG, DePillis GD, Wu JC, Matsuda A and Santi DV. (1988). Biochemistry, 27, 5204-5210.
115. ParikhSS, Putnam CD and Tainer JA. (2000). Mutat. Res., 460, 183-199.
116. Parker WB, Kennedy KA and Klubes P. (1987). Cancer Res., 47, 979-982.
117. Pearl LH. (2000). Mutat. Res., 460, 165-181.
118. Peltomaki P. (2001). Mutat. Res., 488, 77-85.
119. Petronzelli F, Riccio A, Markham GD, Seeholzer SH, Stoerker J, Genuardi M, Yeung AT, Matsumoto Y and Bellacosa A. (2000). J. Biol. Chem., 275, 32422-32429.
120. Reichard P. (1985). Genetic Consequences of Nucleotide Pool Imbalance de Serres FJ (ed). Plenum Press: New York, NY, pp. 33-46.
121. Reichard P. (1988). Annu. Rev. Biochem., 57, 349-374.
122. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M and Gallinger S. (2003). N. Engl. J. Med., 349, 247-257.
123. Richards RG, Sowers LC, Laszlo J and Sedwick WD. (1984). Adv. Enzyme Regul., 22, 157-185.
124. Roberts JD and Kunkel TA. (1988). Proc. Natl. Acad. Sci. USA, 85, 7064-7068.
125. Sancar A and Hearst JE. (1993). Science (Wash. DC), 259, 1415-1420.
126. Santi DV and Hardy LW. (1987). Biochemistry, 26, 8599-8606.
127. Santi DV and McHenry CS. (1972). Proc. Natl. Acad. Sci. USA, 69, 1855-1857.
128. Schuetz JD, Wallace HJ and Diasio RB. (1984). Cancer Res., 44, 1358-1363.
129. Sedwick WD, Kutler M and Brown OE. (1981). Proc. Natl. Acad. Sci. USA, 78, 917-921.
130. Shafman T, Khanna KK, Kedar P, Spring K, Kozlov S, Yen T, Hobson K, Gatei M, Zhang N, Watters D, Egerton M, Shiloh Y, Kharbanda S, Kufe D and Lavin MF. (1997). Nature (Lond.), 387, 520-523.
131. Sowers LC, Eritja R, Kaplan BE, Goodman MF and Fazakerley GV. (1987). J. Biol. Chem., 262, 15436-15442.
132. Sowers LC, Eritja R, Kaplan B, Goodman MF and Fazakerly GV. (1988). J. Biol. Chem., 263, 14794-14801.
133. Sowers LC, Goodman MF, Eritja R, Kaplan B and Fazakerley GV. (1989). J. Mol. Biol., 205, 437-447.
134. Stewart ZA and Pietenpol JA. (2001). Chem. Res. Toxicol., 14, 243-263.
135. Strano S, Rossi M, Fontemaggi G, Munarriz E, Soddu S, Sacchi A and Blandino G. (2001). FEBS Lett., 490, 163-170.
136. Takahashi I and Marmur J. (1963). Nature (Lond.), 197, 794-795.
137. Taverna P, Liu L, Hwang HS, Hanson AJ, Kinsella TJ and Gerson SL. (2001). Mutat. Res., 485, 269-281.
138. van Laar JA, Rustum YM, Ackland SP, van Groeningen CJ and Peters GJ. (1998). Eur. J. Cancer, 34, 296-306.
139. Veigl ML, Kasturi L, Olechnowicz J, Ma AH, Lutterbaugh JD, Periyasamy S, Li GM, Drummond J, ModrichPL, Sedwick WD and Markowitz SD. (1998). Proc. Natl. Acad. Sci. USA, 95, 8698-8702.
140. Venkitaraman AR. (2002). Cell, 108, 171-182.
141. Vikhanskaya F, Colella G, Valenti M, Parodi S, D'Incalci M and Broggini M. (1999). Clin. Cancer Res., 5, 937-941.
142. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ and Qin J. (2000). Genes Dev., 14, 927-939.
143. Wang Q, Zhang H, Guerrette S, Chen J, Mazurek A, Wilson T, Slupianek A, Skorski T, Fishel R and Greene MI. (2001). Oncogene, 20, 4640-4649.
144. Weckbecker G. (1991). Pharmacol. Ther., 50, 367-424.
145. Wilson T, Guerrette S and Fishel R. (1999). J. Biol. Chem., 274, 21659-21664.
146. Yoshioka A, Tanaka S, Hiraoka O, Koyama Y, Hirota Y, Ayusawa D, Seno T, Garrett C and Wataya Y. (1987). J. Biol. Chem., 262, 8235-8241.
147. Yuan Z-M, Shioya H, Ishiko T, Sun X, Gu J, Huang YY, Lu H, Kharbanda S, Weichselbaum R and Kufe D. (1999). Nature (Lond.), 399, 814-817.